| Detected | Trial | Change |
|---|---|---|
| 2026-06-04 | NCT07444905 Prospective Evaluation of a Locked Risk-Stratified Surveillance Strategy for Extrahepatic… |
Primary endpoint(s) modified |
| 2026-06-03 | NCT07350850 A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating… |
Enrollment reduced: 110 -> 77 participants |
| 2026-05-19 | NCT07524699 A Study About Remote and Local Liver Surgery |
Primary endpoint(s) modified |
| 2026-05-19 | NCT07524699 A Study About Remote and Local Liver Surgery |
Enrollment increased: 102 -> 148 participants |
| First Posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-06-10 | NCT07639294 The Application of Locoregional Therapy Combined With Systemic Therapy in the… | Completed | |
| 2026-06-09 | NCT07637214 A Real-world Study: Analysis of the Efficacy of Antiviral Therapy in CHB Patients Over 30… | Completed | |
| 2026-06-01 | NCT07616271 Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and… | Phase 2/3 | Not Yet Recruiting |
| 2026-05-26 | NCT07605611 Somatostatin Plus Clear Liquid Diet Versus Diverting Stoma in Patients With Rectal Cancer… | Recruiting | |
| 2026-05-26 | NCT07606755 Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome | Phase 4 | Recruiting |
| 2026-05-18 | NCT07593833 Prospective Sample Collection Study for a Blood-Based cfDNA Methylation Assay for Ovarian… | Not Yet Recruiting | |
| 2026-05-14 | NCT07587216 Prospective Clinical Database Construction for Liver Cancer Diagnosis and Treatment | Recruiting |
| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 4 | |||
| NCT05303285 | A Study Evaluating the Efficacy of Secukinumab 300mg in Chinese Adults With Active… | Ankylosing Spondylitis (AS) | Recruiting |
| NCT07077486 | Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease | Lupus or SLE | Recruiting |
| NCT07028593 | Effects of Ciprofol on Myocardial Injury After Non-cardiac Surgery in Video-Assisted… | Myocardial Injury | Recruiting |
| NCT07606755 | Clinical Efficacy Study of Jinfeng Pill in the Treatment of Perimenopausal Syndrome | Perimenopausal Syndrome | Recruiting |
| NCT05300932 | A Study Evaluating the Efficacy and Safety of Baricitinib in Systemic Sclerosis | Systemic Sclerosis | Active, Not Recruiting |
| NCT07452445 | Efficacy and Safety of Ivarmacitinib Monotherapy in the Treatment of csDMARDs-IR… | Rheumatoid Arthritis | Not Yet Recruiting |
| Phase 3 | |||
| NCT07002346 | INVIGORATE: A Study of QL1706 and Bevacizumab in Advanced First-Line Ovarian Clear Cell… | Ovarian Clear Cell Carcinoma | Recruiting |
| NCT07537946 | Local Consolidation After Sintilimab Plus Lenvatinib for Metastatic Liver Cancer | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |
| Phase 2/3 | |||
| NCT07616271 | Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and… | Patients With Large B-cell Lymphoma Receiving CAR-T Cell Therapy | Not Yet Recruiting |
| Phase 2 | |||
| NCT07413354 | Tislelizumab Combined With Huaier Granule as First-line Treatment for Unresectable… | Hepatocellular Carcinoma (HCC) | Recruiting |
| NCT07350850 | A Multicenter, Prospective Clinical Trial With a Concurrent Control Evaluating… | PCNSL | Recruiting |
| NCT07350070 | TACE Combined With Tislelizumab, Lenvatinib, and Carvedilol for Unresectable HCC With… | HCC | Not Yet Recruiting |
| NCT07417501 | Lenvatinib Plus PD-1 Inhibitor for Advanced Solid Tumors With 11q13 Amplification | Solid Tumors | Not Yet Recruiting |
| NCT07537972 | Denosumab Strategy for Liver Cancer With Bone Metastases | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting |
| NCT06187961 | HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable… | Hepatocellular Carcinoma Non-resectable | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT07392541 | Adebrelimab Combined With Gemcitabine, Cisplatin, and Simvastatin for Advanced Biliary… | Advanced Biliary Tract Carcinoma | Recruiting |
| Phase 1 | |||
| NCT06552598 | The Safety, Tolerability, and Efficacy of KD01 in Gynecologic Malignancies | Cervical Cancer | Recruiting |
| NCT06620809 | The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders | Neuromyelitis Optica Spectrum Disorders | Recruiting |
| NCT07359235 | Safety, Tolerability, and Preliminary Efficacy of KD01 Via Intravesical Instillation in… | Bladder Cancer (BC) | Recruiting |
| NCT07526493 | Safety and Pharmacodynamics of QH103 Cell Injection in the Treatment of Patients With… | Multiple Sclerosis (MS) | Recruiting |
| NCT05635591 | KSD-101 Therapy for EBV-associated Haematologic Neoplasms: an Exploratory Clinical Trial | EBV-associated Haematologic Neoplasms | Enrolling by Invitation |
| Early Phase 1 | |||
| NCT07339540 | the Safety and Efficacy of Targeted BCMA In Vivo LV Injection for Recurrent or Refractory… | Recurrent or Refractory Systemic Lupus Erythematosus | Recruiting |
| NCT07350837 | CAR-T Therapy Targeting CD19 and BCMA in Highly Sensitized Kidney Transplant Participants | Highly Sensitized Patients Awaiting Kidney Transplant | Recruiting |
| NCT07337785 | CD19/BCMA-Targeted UCAR-T for Patients With Neurological Autoimmune Diseases | Relapsing or Refractory Multiple Sclerosis (MS) | Recruiting |
| NCT06879262 | Clinical Study of Novel TLR2-Containing CAR-T Cells Targeting CD19 and CD22 for… | R/R NHL | Not Yet Recruiting |